Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Nicholas Hewlett, head of St Dunstan’s College private school in southeast London, said staff were worried by a ‘righteous generation’ […]